Diabetes mellitus. Type 2 diabetes mellitus
Conditions
Interventions
Intervention 1: Intervention group in the capsule category: in addition to standard diabetes treatment, one herbal capsule (500 mg) three times a day for two months. Intervention 2: Control group in t
Sponsors
Razi University Vice president of Research and Technology
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Diabetes diagnosis with fasting blood sugar over 125, or postprandial glucose over 200 or glycosylated hemoglobin level greater than 6 Patient willingness and signed informed consent People prone to diabetes due to high weight
Exclusion criteria
Exclusion criteria: Pregnant and breastfeeding Glycosylated hemoglobin over 10 Suffering from chronic and acute kidney, heart and vascular diseases Corticosteroids use Requiring insulin injections or diagnosis of type 1 diabetes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glycosylated hemoglobin blood level. Timepoint: At the beginning of the study, 1 and 2 months after the study. Method of measurement: Medical laboratory.;Fasting glucose serum level. Timepoint: At the beginning of the study, 1 and 2 months after the study. Method of measurement: Medical laboratory.;2 hours postprandial glucose serum level. Timepoint: At the beginning of the study, 1 and 2 months after the study. Method of measurement: Medical laboratory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Lipid Profile. Timepoint: At the beginning of the study, 1 and 2 months after the study. Method of measurement: Medical laboratory.;Liver enzymes. Timepoint: At the beginning of the study, 1 and 2 months after the study. Method of measurement: Medical laboratory. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNasim Batooie
Razi University
Outcome results
None listed